BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4275983)

  • 1. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
    Airaksinen EM; Kauko K
    Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-hydroxyindoles in the cerebrospinal fluid of infants with Down's syndrome and muscle hypotonia.
    Dubowitz V; Rogers KJ
    Dev Med Child Neurol; 1969 Dec; 11(6):730-4. PubMed ID: 4243826
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid.
    Bowers MB
    Biol Psychiatry; 1974 Aug; 9(1):93-8. PubMed ID: 4457119
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients.
    van Praag HM; Korf J
    Biol Psychiatry; 1971; 3(2):105-12. PubMed ID: 5089909
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
    Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
    Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
    [No Abstract]   [Full Text] [Related]  

  • 7. Fate of 14C-labelled tryptophan and 5-hydroxytryptophan in Down's syndrome.
    Airaksinen EM; Airaksinen MM; Pentikäinen P
    Ann Clin Res; 1973 Dec; 5(6):385-91. PubMed ID: 4275982
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin metabolism in depression: clinical application of the probenecid test.
    van Praag HM; Korf J
    Int Pharmacopsychiatry; 1974; 9(1):35-51. PubMed ID: 4599325
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-hydroxyindoleacetic acid in children with Down's syndrome.
    Andersson H; Fällström SP; Lundborg P; Roos BE
    Acta Paediatr Scand; 1973 Mar; 62(2):158-60. PubMed ID: 4266256
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J; Partington MW
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid after intrathecal and intravenous administration of probenecid to normal and hydrocephalic dogs.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):139-47. PubMed ID: 4741034
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of bio-clinical parameters and intelligence in subjects with Down's syndrome and other retardates.
    Klebba JT; Gershbein LL; Marks R
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):159-80. PubMed ID: 4277109
    [No Abstract]   [Full Text] [Related]  

  • 15. Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin.
    Lott IT; Murphy DL; Chase TN
    Neurology; 1972 Sep; 22(9):967-72. PubMed ID: 4263686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amino acids in cerebrospinal fluid of children with Down's syndrome].
    Giza T; Szafran Z; Kobielowa Z; Ostrowski A; St epniewski M
    Pol Tyg Lek; 1972 Jan; 27(4):128-30. PubMed ID: 4258685
    [No Abstract]   [Full Text] [Related]  

  • 17. Tryptophan treatment of infants with Down's syndrome.
    Airaksinen EM
    Ann Clin Res; 1974 Feb; 6(1):33-9. PubMed ID: 4274411
    [No Abstract]   [Full Text] [Related]  

  • 18. 3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
    Gordon EK; Oliver J
    Clin Chim Acta; 1971 Nov; 35(1):145-50. PubMed ID: 4256760
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral hygiene in children with Down's syndrome.
    Pels E; Mielnik-Błaszczak M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):442-7. PubMed ID: 12898877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probenecid on methotrexate exchange between the blood and the cerebrospinal fluid.
    Domer FR; Kaiser LR
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):17-24. PubMed ID: 849061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.